Publications
(click on the titles to see the full text)
Ex Vivo Programmed Cell Death and the Prediction of Response to Chemotherapy.
Nagourney RA., Current Treatment Options in Oncology, Vol 7, issue 2, March 2006
Cisplatin plus Gemcitabine in Platinum Refractory Ovarian or Primary Peritoneal Cancer: A Phase II Study of the Gynecologic Oncology Group
Brewer C, Blessing J, Nagourney RA, et al., Gynecologic Oncology, 2006
Cisplatin plus Gemcitabine in Previously Treated Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group.
Brewer C, Blessing J, McMeekin S, et al., Gynecologic Oncology, 100(2):385-8, Feb 2006
The Once and Future Role of the Platinum Agents in Advanced Breast Cancer.
Robert Nagourney, Clinical Breast Cancer, June 2004
Combining Gemzar With Platinum to Treat Relapsed Ovarian Cancer: An Approach to Addressing Platinum Resistance.
Larry Copeland, RA Nagourney. Eli Lilly, Oncology
Ex-Vivo Analysis of Topotecan: Advancing the Application of Laboratory-Based Clinical Therapeutics.
RA Nagourney, BL Sommers, SM Harper, S Radecki and SS Evans., British Journal of Cancer, (2003) 89, 1789-1795.
Phase II Trial of Gemcitabine plus Cisplatin repeating Doublet Therapy in previously treated, relapsed Ovarian Cancer Patients.
Nagourney RA, Brewer CA, Radecki S, Kidder W, Sommers BL, Evans SS, Minor DR, DiSaia PJ., Gynecologic Oncology, 88, 35-39 (2003)
Herbal Composition of-PC-SPECS for Management of Prostate Cancer: Identification of active principles.
Sovak M, Seligson AL, Konas M, Hajduch M, Dolezal M, Machala M, Nagourney RA., Journal of the National Cancer Institute, Vol 94, No. 17, September 4, 2002
TCL-1 and MTCP-1 Gene Expression in Ataxia-Telangiectasia patients with clonal proliferation or Lymphoid Malignancy
Castellvi-Bel S, Wang Z, Plaeger S, Nagourney RA, Naeim F, Sparkes RS, Gatti RA, Int J.Cancer, 97, 726-731, 2002.
Gemcitabine Plus Cisplatin in Breast Cancer.
Nagourney RA, Oncology, Volume 15, Number 2; pg 28-33. Supplement, January 2001.
Gemcitabine plus Cisplatin repeating Doublet Therapy in relapsed, Heavily pre-treated Breast Cancer Patients.
Nagourney RA, Link JS, Blitzer JB, Forsthoff C, Evans SS., Journal of Clinical Oncology, Vol 18, Issue 11 (June) 2000:2245-2249
Pros& Cons: Doctors Obligated to keep an open mind about alternative treatments
Nagourney RA., Los Angeles Business Journal, January 18, 1999
Oral Limonene: Combined Prenylation Inhibitor Therapy of Cancer.
Nagourney, RA, Journal of Medicinal Food, Volume 1, Number 2, 1998; 83-88
Garlic, Medicinal Foods or Nutritious Treatments?
Nagourney RA, Journal of Medicinal Food, Volume 1, Number 1, 1998; 13-28.